The capacity of PIK-75, gefitinib and c-Met inhibition to impede UWG02CTC invasion was explored in an organotypic cell invasion assay, utilising fibroblast-contracted collagen matrices to recapitulate the tumour-stroma microenvironment of invasive tumour cells [52]. Here, MET is linked to neoplasm.